Raymond James analyst Steven Seedhouse downgraded Editas Medicine (NASDAQ: EDIT) from Outperform to Market Perform.

For an analyst ratings summary and ratings history on Editas Medicine click here. For more ratings news on Editas Medicine click here.

Shares of Editas Medicine closed at $2.91 yesterday.